PELOSI, NANCY BUYNVDA$500K–$1M·TUBERVILLE, TOMMY BUYMSFT$50K–$100K·CRENSHAW, DAN SELLXOM$15K–$50K·PELOSI, NANCY BUYNVDA$500K–$1M·TUBERVILLE, TOMMY BUYMSFT$50K–$100K·CRENSHAW, DAN SELLXOM$15K–$50K·
K-STREET TRACKER

FOLLOW THE MONEY INTO THE SWAMP

Every federal lobbying filing tagged with a public-company ticker — who is spending, which firms they hire, and which members trade right around the filing.

Filings tracked
19,882
thru 2026-05-08
Total reported $
$2.7B
disclosed lobbying
Distinct clients
2,220
paying companies
Tickers targeted
1,207
public companies

💸 Top Spending Clients

🎯 Top Lobbied Tickers

#TickerFilingsTotal $
1META
Meta Platforms Inc.
129$50.2M
2PFE
Pfizer Inc.
87$48.6M
3GM
General Motors Company
103$48.4M
4V
Visa Inc.
46$37.7M
5AMZN
Amazon.com Inc.
80$35.3M
6LMT
Lockheed Martin Corporation
88$29.4M
7FDX
FedEx Corporation
82$28.3M
8LLY
Eli Lilly and Company
83$28.1M
9AMGN
Amgen Inc.
95$28.0M
10MRK
Merck & Co. Inc.
92$27.5M
11AAPL
Apple Inc.
64$26.8M
12GOOGL
Alphabet Inc. Class A
123$26.6M
13MO164$26.2M
14SO
Southern Company
108$26.1M
15UNH
UnitedHealth Group Inc.
67$23.9M
16VZ
Verizon Communications Inc.
116$23.8M
17TMUS159$22.7M
18CHTR137$22.6M
19GD
General Dynamics Corporation
127$22.5M
20T
AT&T Inc.
134$21.6M
21ORCL
Oracle Corporation
132$20.6M
22CMCSA
Comcast Corporation
141$20.4M
23CI
The Cigna Group
64$19.9M
24OXY
Occidental Petroleum Corporation
36$19.9M
25MSFT
Microsoft Corporation
122$19.2M

🆕 Filtered Filings · HUMA

clear filters
DateTickerClientRegistrantAmountIssue
2026-04-21HUMAHUMACYTECAPITOL HILL CONSULTING GROUP$50KIssues related to Medicare reimbursement for biological products. Issues related to Medicare reimbursement for biological products. Issues related to supporting access to biologic products to treat warfighters. Supporting funding for procurement of biologic products to treat post-combat trauma. Issues related to supporting access to biologic products to treat warfighters.
2026-01-20HUMAHUMACYTECAPITOL HILL CONSULTING GROUP$50KIssues related to Medicare reimbursement for biological products. Issues related to Medicare reimbursement for biological products. Issues related to supporting access to biologic products to treat warfighters. Supporting funding for procurement of biologic products to treat post-combat trauma. Issues related to supporting access to biologic products to treat warfighters.
2025-10-21HUMAHUMACYTECAPITOL HILL CONSULTING GROUP$50KPayment for approved medical devices. Payment for approved medical devices. Payment for approved medical devices.
2025-10-20HUMAHUMACYTECAPITOL HILL CONSULTING GROUP$0Payment for approved medical devices. Payment for approved medical devices. Payment for approved medical devices.
2025-10-14HUMAHUMACYTEG2G CONSULTING$0Trauma care
2025-07-13HUMAHUMACYTEG2G CONSULTING$10KTrauma care
2025-04-21HUMAHUMACYTEG2G CONSULTING$10KTrauma care
2025-04-21HUMAHUMACYTE INC.DLA PIPER LLP (US)$0
2025-01-19HUMAHUMACYTEG2G CONSULTING$10KTrauma care